文献速递临床试验与 GCP

严重ARDS患者接受体外膜氧合期间的俯卧位通气:PRONECMO随机临床试验

Prone Positioning During Extracorporeal Membrane Oxygenation in Patients With Severe ARDS: The PRONECMO Randomized Clinical Trial.
PubMed 文献 · JAMA · 2023-01-01

在法国14个ICU开展的多中心随机临床试验,纳入170例接受VV-ECMO不足48小时的严重ARDS患者,1:1分为俯卧位组(n=86)与仰卧位组(n=84)。研究显示两组60天内成功脱离ECMO比例均为44%,风险差0.1%(95%CI -14.9%至15.2%),亚分布风险比1.11(95%CI 0.71-1.75,P=0.64),俯卧位未显著缩短成功脱离ECMO的时间。

要点

  • 俯卧位组与仰卧位组60天内成功脱离ECMO比例均为44%,差异无统计学意义。
  • 90天死亡率俯卧位组51% vs 仰卧位组48%,差异无统计学意义(P=0.62)。
  • 俯卧位操作期间未报告严重不良事件。

核心结论

  • 在VV-ECMO支持的严重ARDS患者中,与仰卧位相比,俯卧位未显著缩短成功脱离ECMO的时间。

研究设计与样本

  • 多中心随机临床试验,在法国14个ICU开展,纳入接受VV-ECMO不足48小时的严重ARDS患者。
  • 2021年3月3日至2021年12月7日期间,170例患者1:1随机分为俯卧位组(n=86,至少4次、每次16小时)与仰卧位组(n=84)。
  • 中位年龄51岁(IQR 43-59),女性60例(35%),中位呼吸系统顺应性15.0 mL/cm H2O(IQR 10.7-20.6)。
  • 159例(94%)为COVID-19相关ARDS,164例(96%)在启动ECMO前处于俯卧位。

主要发现

  • 60天内成功脱离ECMO:俯卧位组38/86(44%)vs 仰卧位组37/84(44%),风险差0.1%(95%CI -14.9%至15.2%),亚分布风险比1.11(95%CI 0.71-1.75),P=0.64。
  • 90天内ECMO持续时间:俯卧位组28天 vs 仰卧位组32天,差值-4.9天(95%CI -11.2至1.5),P=0.13。
  • 90天死亡率:俯卧位组51% vs 仰卧位组48%,风险差2.4%(95%CI -13.9%至18.6%),P=0.62。
  • ICU住院时间无显著差异;俯卧位操作期间未报告严重不良事件。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Prone positioning may improve outcomes in patients with severe acute respiratory distress syndrome (ARDS), but it is unknown whether prone positioning improves clinical outcomes among patients with ARDS who are undergoing venovenous extracorporeal membrane oxygenation (VV-ECMO) compared with supine positioning. OBJECTIVE: To test whether prone positioning vs supine positioning decreases the time to successful ECMO weaning in patients with severe ARDS supported by VV-ECMO. DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial of patients with severe ARDS undergoing VV-ECMO for less than 48 hours at 14 intensive care units (ICUs) in France between March 3, 2021, and December 7, 2021. INTERVENTIONS: Patients were randomized 1:1 to prone positioning (at least 4 sessions of 16 hours) (n = 86) or to supine positioning (n = 84). MAIN OUTCOMES AND MEASURES: The primary outcome was time to successful ECMO weaning within 60 days following randomization. Secondary outcomes included ECMO and mechanical ventilation-free days, ICU and hospital length of stay, skin pressure injury, serious adverse events, and all-cause mortality at 90-day follow-up. RESULTS: Among 170 randomized patients (median age, 51 [IQR, 43-59] years; n = 60 women [35%]), median respiratory system compliance was 15.0 (IQR, 10.7-20.6) mL/cm H2O; 159 patients (94%) had COVID-19-related ARDS; and 164 (96%) were in prone position before ECMO initiation. Within 60 days of enrollment, 38 of 86 patients (44%) had successful ECMO weaning in the prone ECMO group compared with 37 of 84 (44%) in the supine ECMO group (risk difference, 0.1% [95% CI, -14.9% to 15.2%]; subdistribution hazard ratio, 1.11 [95% CI, 0.71-1.75]; P = .64). Within 90 days, no significant difference was observed in ECMO duration (28 vs 32 days; difference, -4.9 [95% CI, -11.2 to 1.5] days; P = .13), ICU length of stay, or 90-day mortality (51% vs 48%; risk difference, 2.4% [95% CI, -13.9% to 18.6%]; P = .62). No serious adverse events were reported during the prone position procedure. CONCLUSIONS AND RELEVANCE: Among patients with severe ARDS supported by VV-ECMO, prone positioning compared with supine positioning did not significantly reduce time to successful weaning of ECMO. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04607551.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Schmidt M, Hajage D, Lebreton G, et al. Prone Positioning During Extracorporeal Membrane Oxygenation in Patients With Severe ARDS: The PRONECMO Randomized Clinical Trial. JAMA. 2023. PMID: 38038395. doi:10.1001/jama.2023.24491

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。